Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinryze for Prevention and Treatment of HAE Attacks in Japanese Subjects
NCT02865720Phase 3Completed
- Sponsor
- Takeda
- Start
- Sep 2016
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Takeda. Started Sep 2016; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT02865720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865720.